(Q42617304)

3 November 2017

title

Invasive Strategies to Achieve Infarct-Related Artery Patency (English)

1 reference

3 November 2017

Smith JJ

1

1 reference

3 November 2017

publication date

1 January 1997

1 reference

Journal of Thrombosis and Thrombolysis

3 November 2017

published in

1 reference

3 November 2017

volume

4

1 reference

3 November 2017

issue

2

1 reference

3 November 2017

page(s)

217-225

1 reference

https://scigraph.springernature.com/pub.10.1023/a:1008874300564

3 November 2017

exact match

0 references

cites work

Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. The Mayo Coronary Care Unit and Catheterization Laboratory Groups

1 reference

12 December 2020

The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction

1 reference

12 December 2020

Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) phase II trial

1 reference

12 December 2020

A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group

1 reference

12 December 2020

Tissue plasminogen activator followed by percutaneous transluminal coronary angioplasty: one-year TIMI phase II pilot results. TIMI Investigators

1 reference

12 December 2020

The western Washington randomized trial of intracoronary streptokinase in acute myocardial infarction. A 12-month follow-up report

1 reference

12 December 2020

Use of direct angioplasty for treatment of patients with acute myocardial infarction in hospitals with and without on-site cardiac surgery. The Myocardial Infarction, Triage, and Intervention Project Investigators

1 reference

12 December 2020

Consequences of reocclusion after successful reperfusion therapy in acute myocardial infarction. TAMI Study Group

1 reference

12 December 2020

Immediate vs delayed catheterization and angioplasty following thrombolytic therapy for acute myocardial infarction. TIMI II A results. The TIMI Research Group

1 reference

12 December 2020

Predictors of in-hospital and 6-month outcome after acute myocardial infarction in the reperfusion era: the Primary Angioplasty in Myocardial Infarction (PAMI) trail

1 reference

12 December 2020

Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty

1 reference

12 December 2020

A randomized trial of late reperfusion therapy for acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction-6 Study Group

1 reference

12 December 2020

Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction

1 reference

12 December 2020

Selection of patients with acute myocardial infarction for thrombolytic therapy

1 reference

12 December 2020

Present status of rescue coronary angioplasty: current polarization of opinion and randomized trials

1 reference

12 December 2020

Aspirin versus coumadin in the prevention of reocclusion and recurrent ischemia after successful thrombolysis: a prospective placebo-controlled angiographic study. Results of the APRICOT Study

1 reference

12 December 2020

Myocardial reperfusion, limitation of infarct size, reduction of left ventricular dysfunction, and improved survival. Should the paradigm be expanded?

1 reference

12 December 2020

A randomized controlled trial of hospital discharge three days after myocardial infarction in the era of reperfusion

1 reference

12 December 2020

Fate of patients with acute myocardial infarction with patency of the infarct-related vessel achieved with successful thrombolysis versus rescue angioplasty

1 reference

12 December 2020

Community hospital administration of intravenous tissue plasminogen activator in acute myocardial infarction: improved timing, thrombolytic efficacy and ventricular function

1 reference

12 December 2020

Value of percutaneous transluminal coronary angioplasty after unsuccessful intravenous streptokinase therapy in acute myocardial infarction

1 reference

12 December 2020

Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Committee on Percutaneous Tran

1 reference

12 December 2020

Cardiogenic shock complicating acute myocardial infarction: the use of coronary angioplasty and the integration of the new support devices into patient management.

1 reference

12 December 2020

SWIFT trial of delayed elective intervention v conservative treatment after thrombolysis with anistreplase in acute myocardial infarction. SWIFT (Should We Intervene Following Thrombolysis?) Trial Study Group

1 reference

12 December 2020

Effects of severity of the residual stenosis of the infarct-related coronary artery on left ventricular dilation and function after acute myocardial infarction

1 reference

12 December 2020

Predictors of early morbidity and mortality after thrombolytic therapy of acute myocardial infarction. Analyses of patient subgroups in the Thrombolysis in Myocardial Infarction (TIMI) trial, phase II

1 reference

12 December 2020

Thrombolytic therapy for acute myocardial infarction. A review

1 reference

12 December 2020

Direct angioplasty for acute myocardial infarction. A review of outcomes in clinical subsets

1 reference

12 December 2020

Evaluation of combination thrombolytic therapy and timing of cardiac catheterization in acute myocardial infarction. Results of thrombolysis and angioplasty in myocardial infarction--phase 5 randomized trial. TAMI Study Group

1 reference

12 December 2020

Randomised trial of coronary intervention with antibody against platelet IIb/IIIa iritegrin for reduction of clinical restenosis: results at six months

1 reference

12 December 2020

Characteristics and outcome of patients in whom reperfusion with intravenous tissue-type plasminogen activator fails: results of the Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) I trial.

1 reference

12 December 2020

Cardiogenic shock after acute myocardial infarction. Incidence and mortality from a community-wide perspective, 1975 to 1988.

1 reference

12 December 2020

A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction

1 reference

12 December 2020

Percutaneous transluminal coronary angioplasty with and without thrombolytic therapy for treatment of acute myocardial infarction

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1008874300564

1 reference

Dimensions Publication ID

3 November 2017

1030365564

0 references

1 reference